ATE473987T1 - Antimitotisches halogeniertes derivat eines vinca-alkaloids - Google Patents
Antimitotisches halogeniertes derivat eines vinca-alkaloidsInfo
- Publication number
- ATE473987T1 ATE473987T1 AT06124480T AT06124480T ATE473987T1 AT E473987 T1 ATE473987 T1 AT E473987T1 AT 06124480 T AT06124480 T AT 06124480T AT 06124480 T AT06124480 T AT 06124480T AT E473987 T1 ATE473987 T1 AT E473987T1
- Authority
- AT
- Austria
- Prior art keywords
- antimitotic
- vinca alkaloid
- halogenated derivative
- formula
- preparation
- Prior art date
Links
- 229940122803 Vinca alkaloid Drugs 0.000 title abstract 2
- 230000002927 anti-mitotic effect Effects 0.000 title abstract 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 abstract 2
- ZEOVXNVKXIPWMS-UHFFFAOYSA-N 2,2-dichloropropane Chemical compound CC(C)(Cl)Cl ZEOVXNVKXIPWMS-UHFFFAOYSA-N 0.000 abstract 1
- 229910021630 Antimony pentafluoride Inorganic materials 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000003797 alkaloid derivatives Chemical class 0.000 abstract 1
- VBVBHWZYQGJZLR-UHFFFAOYSA-I antimony pentafluoride Chemical compound F[Sb](F)(F)(F)F VBVBHWZYQGJZLR-UHFFFAOYSA-I 0.000 abstract 1
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- PQIOSYKVBBWRRI-UHFFFAOYSA-N methylphosphonyl difluoride Chemical group CP(F)(F)=O PQIOSYKVBBWRRI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003930 superacid Substances 0.000 abstract 1
- NMDYYWFGPIMTKO-HBVLKOHWSA-N vinflunine Chemical compound C([C@@](C1=C(C2=CC=CC=C2N1)C1)(C2=C(OC)C=C3N(C)[C@@H]4[C@@]5(C3=C2)CCN2CC=C[C@]([C@@H]52)([C@H]([C@]4(O)C(=O)OC)OC(C)=O)CC)C(=O)OC)[C@H]2C[C@@H](C(C)(F)F)CN1C2 NMDYYWFGPIMTKO-HBVLKOHWSA-N 0.000 abstract 1
- 229960000922 vinflunine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704398A FR2761990B1 (fr) | 1997-04-10 | 1997-04-10 | Derives halogenes antimitotiques d'alcaloides de vinca |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE473987T1 true ATE473987T1 (de) | 2010-07-15 |
Family
ID=9505731
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06124480T ATE473987T1 (de) | 1997-04-10 | 1998-04-10 | Antimitotisches halogeniertes derivat eines vinca-alkaloids |
| AT98920607T ATE270297T1 (de) | 1997-04-10 | 1998-04-10 | Antimitotische halogenierte derivate von vinca alkaloiden |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98920607T ATE270297T1 (de) | 1997-04-10 | 1998-04-10 | Antimitotische halogenierte derivate von vinca alkaloiden |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6127377A (enExample) |
| EP (3) | EP1764368B1 (enExample) |
| JP (3) | JP4401440B2 (enExample) |
| AT (2) | ATE473987T1 (enExample) |
| AU (1) | AU737549C (enExample) |
| BR (2) | BR9816177B1 (enExample) |
| CA (3) | CA2665949C (enExample) |
| CY (2) | CY1111476T1 (enExample) |
| DE (3) | DE69824840T2 (enExample) |
| DK (2) | DK0975640T3 (enExample) |
| ES (2) | ES2222588T3 (enExample) |
| FR (2) | FR2761990B1 (enExample) |
| LU (1) | LU91769I2 (enExample) |
| PT (2) | PT1764368E (enExample) |
| WO (1) | WO1998045301A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2761990B1 (fr) * | 1997-04-10 | 1999-06-25 | Pf Medicament | Derives halogenes antimitotiques d'alcaloides de vinca |
| US6890558B2 (en) * | 2002-05-31 | 2005-05-10 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| EP1694330A4 (en) * | 2003-12-04 | 2009-06-24 | Amr Technology Inc | DERIVATIVES OF VINORELBINE |
| NZ547370A (en) * | 2003-12-04 | 2010-09-30 | Amr Technology Inc | Vinca derivatives |
| US20110015221A1 (en) * | 2003-12-23 | 2011-01-20 | Pierre Fabre Medicament | Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
| CA2607940C (en) | 2005-05-18 | 2009-12-15 | Aegera Therapeutics Inc. | Bir domain binding compounds |
| FR2894966B1 (fr) * | 2005-12-20 | 2008-03-14 | Pierre Fabre Medicament Sa | Nouvelle forme cristalline de la vinflunine |
| MY159563A (en) | 2006-05-16 | 2017-01-13 | Pharmascience Inc | Iap bir domain binding compounds |
| US20080125451A1 (en) * | 2006-09-12 | 2008-05-29 | Amr Technology, Inc. | Vinorelbine derivatives |
| US8039453B2 (en) * | 2006-09-12 | 2011-10-18 | Albany Molecular Research, Inc. | Vinca derivatives |
| FR2905949B1 (fr) * | 2006-09-20 | 2008-11-21 | Pierre Fabre Medicament Sa | Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca |
| FR2910812B1 (fr) | 2006-12-29 | 2009-03-20 | Pierre Fabre Medicament Sa | Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante |
| FR2912406B1 (fr) | 2007-02-13 | 2009-05-08 | Pierre Fabre Medicament Sa | Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine. |
| FR2918566B1 (fr) * | 2007-07-11 | 2009-10-09 | Pierre Fabre Medicament Sa | Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine. |
| FR2918567B1 (fr) * | 2007-07-11 | 2012-08-03 | Pf Medicament | Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine. |
| US20090076055A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched vinflunine |
| DE102010020994B4 (de) * | 2010-01-27 | 2022-01-27 | Interpane Entwicklungs-Und Beratungsgesellschaft Mbh | Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen |
| NZ602368A (en) | 2010-02-12 | 2014-10-31 | Pharmascience Inc | Iap bir domain binding compounds |
| US8940754B2 (en) | 2010-02-22 | 2015-01-27 | The Scripps Research Institute | 10′-fluorinated Vinca alkaloids provide enhanced biological activity against MDR cancer cells |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2707988B1 (fr) * | 1993-07-21 | 1995-10-13 | Pf Medicament | Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant. |
| FR2761990B1 (fr) * | 1997-04-10 | 1999-06-25 | Pf Medicament | Derives halogenes antimitotiques d'alcaloides de vinca |
-
1997
- 1997-04-10 FR FR9704398A patent/FR2761990B1/fr not_active Expired - Lifetime
-
1998
- 1998-04-10 EP EP06124480A patent/EP1764368B1/fr not_active Expired - Lifetime
- 1998-04-10 DE DE69824840T patent/DE69824840T2/de not_active Expired - Lifetime
- 1998-04-10 AT AT06124480T patent/ATE473987T1/de active
- 1998-04-10 AU AU73408/98A patent/AU737549C/en not_active Expired
- 1998-04-10 US US09/402,678 patent/US6127377A/en not_active Expired - Lifetime
- 1998-04-10 EP EP20030017052 patent/EP1357125A3/fr not_active Ceased
- 1998-04-10 BR BRPI9816177-6A patent/BR9816177B1/pt not_active IP Right Cessation
- 1998-04-10 JP JP54247098A patent/JP4401440B2/ja not_active Expired - Lifetime
- 1998-04-10 CA CA2665949A patent/CA2665949C/fr not_active Expired - Lifetime
- 1998-04-10 DK DK98920607T patent/DK0975640T3/da active
- 1998-04-10 EP EP98920607A patent/EP0975640B1/fr not_active Expired - Lifetime
- 1998-04-10 DE DE69841766T patent/DE69841766D1/de not_active Expired - Lifetime
- 1998-04-10 ES ES98920607T patent/ES2222588T3/es not_active Expired - Lifetime
- 1998-04-10 PT PT06124480T patent/PT1764368E/pt unknown
- 1998-04-10 CA CA002286560A patent/CA2286560C/fr not_active Expired - Lifetime
- 1998-04-10 ES ES06124480T patent/ES2347878T3/es not_active Expired - Lifetime
- 1998-04-10 AT AT98920607T patent/ATE270297T1/de active
- 1998-04-10 WO PCT/FR1998/000730 patent/WO1998045301A1/fr not_active Ceased
- 1998-04-10 PT PT98920607T patent/PT975640E/pt unknown
- 1998-04-10 DK DK06124480.2T patent/DK1764368T3/da active
- 1998-04-10 CA CA2455416A patent/CA2455416C/fr not_active Expired - Lifetime
- 1998-04-10 DE DE122010000054C patent/DE122010000054I1/de active Pending
- 1998-04-10 BR BRPI9807944-1A patent/BR9807944B1/pt not_active IP Right Cessation
-
2004
- 2004-03-03 JP JP2004059502A patent/JP4307292B2/ja not_active Expired - Lifetime
-
2009
- 2009-03-11 JP JP2009058098A patent/JP2009167196A/ja active Pending
-
2010
- 2010-09-27 FR FR10C0045C patent/FR10C0045I2/fr active Active
- 2010-10-14 CY CY20101100917T patent/CY1111476T1/el unknown
- 2010-12-22 LU LU91769C patent/LU91769I2/fr unknown
- 2010-12-22 CY CY2010019C patent/CY2010019I1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR10C0045I2 (fr) | Derive halogene antimitotique d'alcaloide de vinca | |
| UA6340A1 (uk) | Спосіб одержання заміщених діазабіціклоалкілхінолон карбонових кислот мостиковим зв'язком або їх фармацевтично прийнятних адитивний солей | |
| YU97292A (sh) | N-fenilalanil i n-fenilglicil derivati dipeptida l-azetidin-2-karboksilne kiseline | |
| SE7508332L (sv) | Sett att framstella 3-kinolin-karboxylsyraderivat och anvendning derav som lekemedel. | |
| AU8176982A (en) | 9-(2-(3-indolyl)ethyl)-1-oxa-4,9-diazaspiro(5,5)undecan 3-ones | |
| NZ510310A (en) | Process for preparing N,N,6- trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]-pyridine-3-acetamide and its salts | |
| IT1248743B (it) | Metodo per la preparazione, in una forma non-racemica, di derivati della furo <3,4-c> piridina | |
| ATE29721T1 (de) | 5-(4-vinyl- oder 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo-(1,2-a -pyrrol-1-carbosaeure und deren derivate. | |
| GR861782B (en) | Method for preparing n-methyl derivatives of ergoline | |
| HUT40090A (en) | New process for production of derivatives of hh-1,2,4-triasole | |
| US4122081A (en) | 5'-Hydroxyleurosine and related compounds | |
| DE3873786D1 (de) | Substituierte 1,3,4,9-tetrahydropyrano(3,4-b)indol-1-essigsaeuren. | |
| JPS5520723A (en) | Preparation of cephalosporin compound | |
| ATA71691A (de) | Neue thiophen-2-carbonsaeurederivate und verfahren zu deren herstellung | |
| JPS5759896A (en) | Production of thiazolineazetidinone derivative | |
| US4175080A (en) | Process of producing 5'-hydroxyleurosine and related compounds | |
| KR950032210A (ko) | 8-아미노-10-(아자비사이클로알킬)-피리도[1,2,3-d,e][1,3,4] 벤족사디아진유도체 | |
| US4379936A (en) | Nortropane derivatives | |
| JPS5718680A (en) | Indole derivative | |
| JPS57136586A (en) | Cephalosporin derivative and its preparation | |
| JPS51113890A (en) | Method for preparing novel cephalosporins | |
| SE7612319L (sv) | Forfarande for framstellning av bensomorfanderivat. | |
| JPS54148750A (en) | Novel halogenoacetanilide derivative and its preparation | |
| HUT57779A (en) | Process for producing new thiazetoquinoline-3-carboxylic acid derivatives | |
| JPS5246097A (en) | Method of preparing pyrrlobenzodiazpins or acid addition salts thereof |